Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Koninklijke Philips N.V.NYSE: PHG

Revenue · Q2 FY2026 · quarter ended Jun 2026

Revenue grows in line with its trailing trend

Q2 FY2026 revenue of €4.36B rose 0.5% year over year, ahead of the -1.1% change in trailing-twelve-month revenue. Sequentially, it rose 11.7% from the prior quarter. Over 3 fiscal years it compounded at +0.0% a year.

Context

  • Revenue increased in 1 of the last 3 fiscal years.

What to watch

Whether revenue reaches the consensus estimate from 10 analysts of €18.1B (+1.5%) for the fiscal year ending Dec 2026, a step up from the -1.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
€4.36B+11.7% QoQ
Last fiscal yearDec 2025
€17.83B-1.0% YoY
LTMJun 2026
€17.66B-1.1% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.5%+4.2%+3.7 pp
1 year-1.0%+1.5%+2.5 pp
3-year CAGR+0.0%+3.6%+3.6 pp
5-year CAGR+3.9%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

EUR · from the income statement

Latest · FY2025
17.83B EUR
Year-over-year change
-1.0%
4-year CAGR
+1.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How PHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -1.1% is the lowest of 10, against a peer median of +10.0%.
  • Over three fiscal years its annual growth of +0.0% compares with a peer median of +10.2%.
PHG Competitors
Revenue for PHG and competitors
Company Period LTM YoY 3-year CAGR
ABTAbbott LaboratoriesLTM Sep 2026$48.23B USD+10.0%+0.5%
MDTMedtronic plcLTM Jul 2026$37.54B USD+9.8%+5.2%
BSXBoston Scientific CorporationLTM Jun 2026$21B USD+13.5%+16.5%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$20.24B USD+1.4%+4.0%
PHGKoninklijke Philips N.V.LTM Jun 2026€17.66B EUR-1.1%+0.0%
SNNSmith & Nephew plcFY2025$6.16B USD+6.1%+5.7%
RMDResMed Inc.LTM Jun 2026$5.65B USD+9.9%+10.2%
LIVNLivaNova PLCLTM Sep 2026$1.51B USD+11.7%+10.8%
NPCENeuroPace, Inc.LTM Mar 2026$99.53M USD+18.1%+30.0%
IRMDIRadimed CorporationLTM Mar 2026$86.28M USD+14.8%+16.3%
Peer median (excluding PHG) —+10.0%+10.2%

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.16B17.83B18.17B18.02B17.83B
Cost of Revenue9.99B10.63B10.72B10.25B9.78B
Gross Profit7.17B7.19B7.45B7.77B8.06B
Gross Margin41.8%40.4%41.0%43.1%45.2%
Research & Development1.81B2.09B1.89B1.75B1.7B
Selling, General & Admin4.86B5.29B5.13B5.07B4.97B
Operating Expenses6.62B8.72B7.56B7.24B6.63B
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
EBITDA2B115M1.04B1.85B2.64B
EBITDA Margin11.6%0.6%5.7%10.3%14.8%
Operating Income553M(1.53B)(115M)529M1.42B
Operating Margin3.2%-8.6%-0.6%2.9%8.0%
Interest Income18M25M46M79M108.54M
Interest Expense164M244M306M337M332.34M
Other Income / Expenses(44M)(202M)(412M)(406M)(242M)
Income Before Tax509M(1.73B)(527M)123M1.18B
Pre-Tax Margin3.0%-9.7%-2.9%0.7%6.6%
Income Tax Expense(103M)(113M)(73M)963M282M
Net Income3.32B(1.61B)(466M)(702M)895M
Net Margin19.3%-9.0%-2.6%-3.9%5.0%
EPS (Basic)0.67(1.68)(0.49)(0.75)0.95
EPS (Diluted)0.64(1.68)(0.49)(0.75)0.93
Weighted Avg Shares907.46M952.46M948.79M933.37M962.37M
Weighted Avg Shares (Diluted)950.28M952.46M948.79M933.37M962.5M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.